HomeENBI • CNSX
add
Entheon Biomedical Corp
Previous close
$0.10
Year range
$0.090 - $0.45
Market cap
3.17M CAD
Avg Volume
9.57K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 149.20K | 91.46% |
Net income | -145.61K | -94.51% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 525.16K | 110.13% |
Total assets | 563.17K | 92.93% |
Total liabilities | 63.45K | 24.40% |
Total equity | 499.72K | — |
Shares outstanding | 13.86M | — |
Price to book | 2.50 | — |
Return on assets | -99.69% | — |
Return on capital | -115.65% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | -145.61K | -94.51% |
Cash from operations | -111.33K | -17.55% |
Cash from investing | — | — |
Cash from financing | 500.00K | — |
Net change in cash | 388.67K | 510.37% |
Free cash flow | -58.97K | 13.98% |
About
Founded
Jun 2019
Headquarters
Website
Employees
1
